Ernexa Therapeutics Inc. Share Price
Ernexa Therapeutics Inc. (ERNA) had Share Price of $2.18 per share as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2023-11-13
- 2023-09-30: Share Price $2.18.
- 2023-06-30: Share Price $2.26.
- 2023-03-31: Share Price $3.40.
- 2022-09-30: Share Price $4.94.
| Period end | Share Price | Share Price as first filed |
|---|---|---|
| 2023-09-30 | $2.18 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.26 10-Q · filed 2023-11-13 | |
| 2023-03-31 | $3.40 10-Q · filed 2023-08-11 | |
| 2022-09-30 | $4.94 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $10.40 10-Q · filed 2022-11-14 | $0.52 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.05 10-Q · filed 2022-08-11 | |
| 2021-12-31 | $4.17 10-Q · filed 2022-07-01 | |
| 2021-03-25 | $5.40 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |